Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro - Concepedia

Concepedia

Publication | Open Access

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro

DOI Full Paper Access

110

Citations

37

References

2021

Year

Sebastian Schloer, Linda Brunotte, Angeles Mecate‐Zambrano, Shuyu Zheng, Jing Tang, Stephan Ludwig, Ursula Rescher

British Journal of Pharmacology

Abstract

Itraconazole-remdesivir and fluoxetine-remdesivir combinations are promising starting points for therapeutic options to control SARS-CoV-2 infection and severe progression of COVID-19.

References

	Year	Citations

Page 1